Treatment Options, Clinical Pathways, and Collaborative Care: A Multiple Myeloma Update for Managed Care and Specialty Pharmacy
Satellite Dinner Symposium
Treatment Options, Clinical Pathways, and Collaborative Care: A Multiple Myeloma Update for Managed Care and Specialty Pharmacy

Jointly provided by Impact Education, LLC and Postgraduate Institute for Medicine.
Impact Education, LLC     Postgraduate Institute for Medicine
This activity is supported by independent educational grants from Celgene Corporation and Takeda Oncology.
Wednesday, March 29, 2017
6:00 PM - 8:00 PM
Colorado Convention Center
Room Mile High 1A-1C
Denver, CO


Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017 is required.
Held in conjunction with

AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017.


Click here to download the slides from this symposium.

Don't miss this additional, free live CE webcast on multiple myeloma:
Treatment Options, Clinical Pathways, and Collaborative Care: A Multiple Myeloma Update for Managed Care and Specialty Pharmacy Live Webcast
  HOT TOPICS
  • Patient advocate testimonial from multiple myeloma survivor, Yelak Biru
  • Innovative oncology pharmacy benefit models
  • The value of clinical pathways initiatives as a means of improving clinical and economic outcomes
  • Recent clinical data affecting evidence-based treatment guidelines
  DISTINGUISHED FACULTY PRESENTERS
Yelak Biru
Patient Advocate
North Texas Myeloma Support Group
IMF Global Myeloma Action Network
Jeffrey Dunn, PharmD, MBA
Senior Vice President
Chief Clinical Officer
VRx/MagellanRx
Carol Ann Huff, MD
Associate Professor of Oncology and Medicine
Director, Multiple Myeloma Program
Medical Director, Department of Oncology Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Edmund Pezalla, MD, MPH
CEO
Enlightenment Bioconsulting
  WHO SHOULD ATTEND?

This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of AMCP, and other managed health care professionals attending AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017.

  STATEMENT OF NEED / PROGRAM OVERVIEW

The management of multiple myeloma (MM) is a priority area for MCOs in order to optimize clinically- and economically-appropriate care for their members. As novel agents become available, treatment decision making is becoming more complex and MCOs and other payer organizations need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes. Guidance is needed for the target audience to implement current guidelines, utilize clinical pathways, design appropriate medical and pharmacy benefits, and implement effective specialty pharmacy management services.

This interactive program is designed to engage the faculty and audience to develop solutions for managed care professionals to implement within their own setting to improve outcomes for patients with MM. Multidisciplinary faculty will be utilized featuring a managed care medical director, a pharmacy director, and a hematology/oncology expert.

An innovative approach to the activity's curriculum will feature a multiple myeloma patient testimonial and three faculty demonstrating the unique value each brings to the overall care of patients with MM through real world examples and case studies. By working together via data sharing and collaboration between payers, hematologists/oncologists, specialty pharmacy, and patients, on a more integrated approach, current barriers will be overcome, demonstrating value to all parties and motivating them to become further engaged.

  EDUCATIONAL OBJECTIVES

At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Evaluate recent clinical data affecting evidence-based treatment guidelines for MM
  • Demonstrate the value of clinical pathways initiatives as a means of reducing treatment variability and improving clinical and economic outcomes in the management of MM
  • Implement comprehensive care strategies involving effective communication methods
  • Integrate innovative oncology pharmacy benefit models with specialty pharmacy management services
  AGENDA

Date and Time
Wednesday, March 29, 2017
6:00 PM - 8:00 PM
Colorado Convention Center
Room Mile High 1A-1C
Denver, CO

6:00 PM Dinner and Registration
6:05 PM Pre-Activity Learning Assessment and Key Learning Points
Jeffrey Dunn, PharmD, MBA
6:10 PM The Expanding Treatment Armamentarium and Evolving Clinical and Supportive Care Guidelines
Carol Ann Huff, MD
6:40 PM Practical Strategies for the Implementation of Clinical Pathways
Edmund Pezalla, MD, MPH
7:10 PM Innovative Oncology Pharmacy Benefit Models and Specialty Pharmacy Management Services
Jeffrey Dunn, PharmD, MB
7:30 PM Patient/Survivor's Perspective on the Evolving Treatments in Multiple Myeloma: Quality of Life Considerations
Yelak Biru
7:45 PM Audience Question & Answer Session Key Takeaways and Closing Comments, and Post-Activity Assessment with Peer Benchmarking
8:00 AM Adjournment
  ACCREDITATION INFORMATION
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - 0809-9999-17-407-L01-P

Type of Activity: Application

For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from CEcertificate@pimed.com within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
No additional fee is required to attend this CPE/CME activity.

Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017 is required.

Pre-registration will close at 12:00 pm on March 28, 2017.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.